巴克莱双倍上调评级，Alvotech股价上涨 (ALVO:NASDAQ)
· seekingalpha.com
Alvotech (ALVO) 股价上涨，因巴克莱在美国食品药品监督管理局关键审批决定前将该公司评级从“减持”上调至“增持”。在此阅读更多内容。
Alvotech (ALVO) traded higher on Wednesday after Barclays upgraded the drugmaker to Overweight from Underweight, citing a compelling risk-reward setup ahead of ...